Literature DB >> 10464352

Intestinal inflammation and the gut microflora.

D M McKay1.   

Abstract

The idea that the enteric microflora play a role in the pathogenesis or pathophysiology of inflammatory bowel disease (IBD) is not new. Indeed, identification of an infective cause for chronic IBD, and particularly for Crohn's disease, has been the focus of extensive research efforts. During the 1990s, there has been a noticeable re-emergence of interest in the link between bacteria and functional bowel disorders, and the value of antibiotic therapy to treat gut inflammatory disorders. A variety of experimental evidence from both laboratory model systems and clinical investigations is reviewed with respect to a pivotal role for enteric bacteria in gut inflammation. The voluminous scientific literature on this subject precludes any comprehensive synopsis of the area; instead, pertinent studies are cited to illustrate the ability of bacteria and their products to evoke or exacerbate gut inflammation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10464352     DOI: 10.1155/1999/680206

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  9 in total

1.  Effect of bacterial chemotactic peptides on intestinal inflammation in animal models of acute and chronic "relapsed" colitis.

Authors:  Gerardo A Hernández; Melanie R Valentín; Caroline B Appleyard
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

2.  Enterocyte cytoskeleton changes are crucial for enhanced translocation of nonpathogenic Escherichia coli across metabolically stressed gut epithelia.

Authors:  Aisha Nazli; Arthur Wang; Oren Steen; David Prescott; Jun Lu; Mary H Perdue; Johan D Söderholm; Philip M Sherman; Derek M McKay
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice.

Authors:  K Yoshihara; T Yajima; C Kubo; Y Yoshikai
Journal:  Gut       Date:  2005-09-14       Impact factor: 23.059

Review 4.  Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning.

Authors:  Chang-Qing Zheng; Gang-Zheng Hu; Zhao-Shu Zeng; Lian-Jie Lin; Gin-Ge Gu
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

5.  Epithelia under metabolic stress perceive commensal bacteria as a threat.

Authors:  Aisha Nazli; Ping-Chang Yang; Jennifer Jury; Kathryn Howe; James L Watson; Johan D Söderholm; Philip M Sherman; Mary H Perdue; Derek M McKay
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

6.  Rhinosinusitis derived Staphylococcal enterotoxin B possibly associates with pathogenesis of ulcerative colitis.

Authors:  Ping-Chang Yang; Tao Liu; Bin-Quan Wang; Tao-Yuan Zhang; Zi-Yuan An; Peng-Yuan Zheng; Dao-Fa Tian
Journal:  BMC Gastroenterol       Date:  2005-09-06       Impact factor: 3.067

7.  Mycobacterium avium subsp. paratuberculosis and microbiome profile of patients in a referral gastrointestinal diseases centre in the Sudan.

Authors:  Wisal A Elmagzoub; Sanaa M Idris; Maha Isameldin; Nassir Arabi; Abdelmonem Abdo; Mustafa Ibrahim; Md Anik Ashfaq Khan; Franziska Tanneberger; Sahar M Bakhiet; Julius B Okuni; Lonzy Ojok; Ahmed A Gameel; Ahmed Abd El Wahed; Michaël Bekaert; Mohamed E Mukhtar; Ahmad Amanzada; Kamal H Eltom; ElSagad Eltayeb
Journal:  PLoS One       Date:  2022-04-05       Impact factor: 3.240

8.  Effects of embryo injected with ochratoxins A on hatching quality and jejunum antioxidant capacity of ducks at hatching.

Authors:  Jinhui Liu; Xiayu Jiang; Xin Peng; Yihan Yuan; Yu Shen; Yongxia Li; Zixing Yan; Xi Yuan; Ye Yang; Shuangshuang Zhai
Journal:  Front Vet Sci       Date:  2022-08-09

9.  Crucial role for CD69 in the pathogenesis of dextran sulphate sodium-induced colitis.

Authors:  Akihiro Hasegawa; Chiaki Iwamura; Masayuki Kitajima; Kahoko Hashimoto; Ken-Ichiro Otsuyama; Hidetaka Ogino; Toshinori Nakayama; Mutsunori Shirai
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.